expansion slot

expansion slot Cyber Monday is now behind us, but there are still plenty of worthy deals on perfect holiday gifts across all categories if you know where to look. We've spotted Breville kitchen appliances discounted at Target , which means you have gifting options for any foodies in your life. But there's more: Amazon is also offering discounts on Breville gear, and you can acquire quality coffee, espresso makers and other kitchen tools for less just in time for the holidays if you order soon. Prices at both Target and Amazon tend to change quickly, and stocks tend to run out quickly this time of year, so act fast if you're interested in saving hundreds on these popular items. Why these Breville deals matter Breville is known for making smart kitchen appliances that bring a more professional touch into your home. From toaster ovens to juicers to coffee makers, the brand's wares are perfect for tech enthusiasts who love good food. Some of these devices typically run hundreds of dollars but these deals at both Amazon and Target mean you can save up to $325, making it a bit more affordable. These savings are on par with recent Black Friday and Cyber Monday deals. Hey, did you know? CNET Deals texts are free, easy and save you money If you need a space-saving toaster oven, the Breville 1800W smart toaster is now on sale for $150 at Target , saving you $40. It has 8 cooking functions and can fit a whole chicken or even a 12-inch pizza. After you're done cooking, you can clean some of its parts in the dishwasher for less fuss. Coffee and espresso lovers will also enjoy the $150 discount on the Breville Barista Express, a 15-bar espresso maker that can grinds coffee beans and lets you make professional-grade espresso at home for just $550 at both Target and Amazon . For folks who love to host gatherings and want to truly recreate a café experience at home, the Breville Barista is a full $325 off right now at Amazon , costing $675 for this stainless steel, fully-equipped espresso maker. The entire selection of Breville deals is worth perusing, and some of these discounts amount to hundreds off excellent kitchen appliances. If you're looking for more stocking-stuffers but aren't sure if these deals are for you, check out our list of the best remaining Amazon Cyber Monday deals . CNET is always covering a wide array of deals on tech products and much more. Start with the hottest sales and discounts on the CNET Deals page , and sign up for the CNET Deals Text to get daily deals sent straight to your phone. Add the free CNET Shopping extension to your browser for real-time price comparisons and cash-back offers. And peruse our gift guide , which includes a full range of ideas for birthdays, anniversaries and more.49ers QB Brock Purdy, DE Nick Bosa out, Brandon Allen to start at Green Bay

AWH Partners Promotes Dev Sharma as Director of AnalyticsAvalanche Analysis: GM Chris MacFarland attempts to fix goaltending issues with bold, risky tradeKidman, Pearce, Blanchett and Watts nominated for Golden Globes

HAYWARD, Calif.--(BUSINESS WIRE)--Dec 23, 2024-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field AblationTM (nano-PFA or nsPFATM) technology, today announced that it intends to deliver an irrevocable notice of redemption, on or about December 27, 2024, to redeem the first tranche of common stock warrants, redeemable by the Company if the Company’s stock trading price exceeds $16.50 for twenty consecutive trading days, that were issued as part of its July 3, 2024 rights offering which are still outstanding as of February 5, 2025 (the “Redemption Date”). These outstanding common stock warrants (the “150% Warrants”), which were issued in the Company’s 2024 rights offering (the “Rights Offering”), pursuant to the Company’s Registration Statement on Form S-3, as amended (File No. 333-278494), may be exercised by the holders thereof until 6:30 p.m., Eastern time, on the Redemption Date, at the exercise price of $11.00 per share of Company common stock, $0.001 par value per share. Any 150% Warrants not exercised before 6:30 p.m., Eastern time, on February 5, 2025, will be redeemed by the Company for $0.01 per 150% Warrant share (the “Redemption Price”). Under the terms of the 150% Warrants, the Company has the right to redeem the 150% Warrants (CUSIP # 74587B135) if the volume weighted average price (as defined therein, “VWAP”) exceeds $16.50 per share for twenty (20) consecutive trading days at least three months after the date that the 150% Warrants were issued. This requirement was met for each of the twenty consecutive trading days preceding December 23, 2024. Over this period, the Company had an average VWAP of $18.85. Any 150% Warrants that remain unexercised at 6:30 p.m., Eastern time, on the Redemption Date, will be void and no longer exercisable, and the holders of those 150% Warrants will be entitled to receive only the Redemption Price of $0.01 per 150% Warrant share. The second tranche of common stock warrants issued in the Rights Offering (the “200% Warrants”) are not being redeemed at this time. The Company received aggregate gross proceeds of $60 million from its Rights Offering, which was completed in July 2024, and the Company will receive an additional $66 million of gross proceeds, if all of the 150% Warrants and all of the 200% Warrants (collectively, the “Warrants”) are exercised prior to the Redemption Date. None of the Company, its board of directors or employees has made or is making any representation or recommendation to any holder of any Warrants as to whether to exercise or refrain from exercising any Warrants. A registration statement, as amended, relating to the Rights Offering was previously filed with the Securities and Exchange Commission (the “SEC”) and declared effective on May 31, 2024. A prospectus relating to the offering was filed with the SEC on and supplemented on June 4, 2024 and is available on the SEC’s website. The Company will post a copy of the notice of redemption being sent to the holders of the 150% Warrants on its investor relations website at investors.pulsebiosciences.com . Questions concerning redemption and exercise of the 150% Warrants can be directed to Broadridge Corporate Issuer Solutions, LLC, Attn: BCIS Re-Organization Dept., P.O. Box 1317, Brentwood, NY 11717-0718, telephone number 888-789-8409 or to shareholder@broadridge.com . No Offer or Solicitation This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any offer of any of the Company’s securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. About Pulse Biosciences® Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The Company’s proprietary CellFX® nsPFATM technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is actively pursuing the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. Pulse Biosciences is now headquartered in Miami, Florida and maintains its office in Hayward, California. Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries. Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company’s planned redemption of outstanding warrants, statements concerning its expected product development efforts, statements about its Nanosecond Pulsed Field Ablation (nsPFA) technology to non-thermally clear cells while sparing adjacent noncellular tissue, as well as statements concerning customer adoption and future use of the CellFX System to address a range of conditions such as atrial fibrillation. These statements are not historical facts but rather are based on Pulse Biosciences’ current expectations, estimates, and projections regarding Pulse Biosciences’ business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond Pulse Biosciences’ control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Pulse Biosciences’ filings with the Securities and Exchange Commission. Pulse Biosciences undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available. View source version on businesswire.com : https://www.businesswire.com/news/home/20241223275716/en/ CONTACT: Investor Contacts: Pulse Biosciences Darrin Uecker, CTO or Kevin Danahy, CCO IR@pulsebiosciences.com or Gilmartin Group Philip Trip Taylor 415.937.5406 philip@gilmartinir.com KEYWORD: CALIFORNIA FLORIDA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES HEALTH PHARMACEUTICAL CARDIOLOGY SOURCE: Pulse Biosciences, Inc. Copyright Business Wire 2024. PUB: 12/23/2024 04:30 PM/DISC: 12/23/2024 04:30 PM http://www.businesswire.com/news/home/20241223275716/enMatt Gaetz says he won’t return to Congress next year after withdrawing name for attorney general

NEW YORK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Sun Communities, Inc. (“SUI” or the “Company”) (NYSE: SUI) between February 28, 2019 and September 24, 2024, both dates inclusive . You are hereby notified that the class action lawsuit Michelle Nelson v. Sun Communities, Inc., et al. (Case No. 2:24-cv-13314) has been commenced in the United States District Court for the Eastern District of Michigan. To get more information go to: https://zlk.com/pslra-1/sun-communities-inc-lawsuit-submission-form or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you. The complaint alleges that defendants provided investors with material information concerning SUI’s accounting practices and internal control over financial reporting. On September 24, 2024, after market close, an investment research report emerged calling into question the integrity of SUI’s Board and the integrity of the Company’s governance, controls, and financial disclosures. Investors and analysts reacted immediately to SUI’s revelation. The price of SUI’s common stock declined dramatically. From a closing market price of $139.10 per share on September 24, 2024, SUI’s stock price fell to a low of $137.48 per share on September 25, 2024. If you suffered a loss in SUI securities , you have until February 10, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States. CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. Ed Korsinsky, Esq. 33 Whitehall Street, 17th Floor New York, NY 10004 jlevi@levikorsinsky.com Tel: (212) 363-7500 Fax: (212) 363-7171 www.zlk.comRepresentatives pose for a picture after El Salvador's Congress approved a bill from President Nayib Bukele that overturned a 2017 national ban on metals mining in San Salvador, El Salvador, on Dec. 23. Jose Cabezas/Reuters El Salvador’s legislature overturned a seven-year-old ban on metals mining on Monday, a move that President Nayib Bukele had pushed for to boost economic growth, but that environmental groups had opposed. El Salvador became the first country in the world to ban all forms of metals mining in 2017. Bukele, who took office in 2019, has called the ban absurd. All 57 of Bukele’s allies in the Central American country’s 60-seat legislature voted for the president’s legislation to overturn the ban. The legislation will grant the Salvadoran government sole authority over mining activities within the country’s land and maritime territory. “By creating a law that puts the state at the centre, we are guaranteeing that the population’s well-being will be at the centre of decision making,” lawmaker Elisa Rosales, from Bukele’s New Ideas party, said in a speech to the legislature. The legislation does prohibit the use of mercury in mining, and seeks to declare some areas incompatible with metals mining as protected nature reserves. El Salvador’s economy is expected to grow 3 per cent this year, according to the International Monetary Fund, but it has a heavy debt burden that hit a level of around 85 per cent of gross domestic product earlier this year. Bukele, who enjoys wide popularity among voters after a gang crackdown, has touted mining’s economic potential for the country of roughly 6 million people. The president shared on social media last month that studies conducted in just 4 per cent of Salvadoran territory where mining is possible had identified gold deposits worth some $132 billion, equivalent to about 380 per cent of El Salvador’s GDP. “This wealth, given by God, can be harnessed responsibly to bring unprecedented economic and social development to our people,” Bukele wrote at the time. Dozens of people protested on Monday near Congress against the reauthorization of mining, arguing that future projects could affect the communities and ecosystem of the smallest country in Central America. “We oppose metals mining because it has been technically and scientifically proven that mining is not viable in the country,” environmentalist Luis Gonzalez told reporters. “The level of contamination that would be generated in the water, soil and biodiversity is unacceptable for life as we know it.”With Jose Oquendo as his guide, Willson Contreras set to launch move to first in Jupiter